A Phase I Randomised Controlled Trial to Evaluate Safety and Clinical Effect of Topically Applied GSK2981278 Ointment in a Psoriasis Plaque Test.
Kang EG, Wu S, Gupta A, von Mackensen YL, Siemetzki H, Freudenberg JM, Wigger-Alberti W, Yamaguchi Y.
Br J Dermatol. 2018 Jun;178(6):1427-1429
Abstract

Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
Blume-Peytavi U, Issiakhem Z, Gautier S, Kottner J, Wigger-Alberti W, Fischer T, Hoffmann R, Tonner F, Bouroubi A, Voisard JJ
J Cosmet Dermatol. 2018 Apr 16. doi: 10.1111/jocd.12541. [Epub ahead of print]
Abstract

Dermocosmetics for Use in Rosacea: Guideline of the Society for Dermopharmacy.
Kresken J, Kindl U, Wigger-Alberti W, Clanner-Engelshofen BM, Reinholz M
Skin Pharmacol Physiol. 2018 Mar 29;31(3):147-154. doi: 10.1159/000486688. [Epub ahead of print]
Abstract

Comparison of Occlusive and Open Application in a Psoriasis Plaque Test Design. Exemplarily Using Investigations of Mapracorat 0.1% Ointment versus Vehicle and Reference Drugs.
Wigger-Alberti W, Williams R, von Mackensen YL, Hoffman-Wecker M, Grossmann U, Staedler G, Nkulikiyinka R, Shakery K.
Skin Pharmacol Physiol. 2017;30(2): 102-114.
Abstract

Clinical trial shows lasting function of a new moisturizing cream against vaginal dryness.
Henneike-von Zepelin HH, Williams R, Havemeister W, Wigger-Alberti W, Nolte KU
Wien Med Wochenschr. 2017 May;167(7-8): 189-195.
Abstract

Confocal Raman microscopy and multivariate statistical analysis for determination of different penetration abilities of caffeine and propylene glycol applied simultaneously in a mixture on porcine skin ex vivo.
Mujica Ascencio S, Choe C, Meinke MC, Müller RH, Maksimov GV, Wigger-Alberti W, Lademann J, Darvin ME
Eur J Pharm Biopharm. 2016 Jul;104:51-8.
Abstract

A phase I randomized trial to assess the effect on skin infiltrate thickness and tolerability of topical phosphodiesterase inhibitors in the treatment of psoriasis vulgaris using a modified psoriasis plaque test.
Snape SD, Wigger-Alberti W, Goehring UM
Br J Dermatol. 2016 Sep;175(3):479-86.
Abstract

Cumulative irritation, sensitizing potential, phototoxicity and photoallergy of ozenoxacin in healthy adult volunteers.
Gropper S, Cepero AL, Dosik JS, LaStella KP, Siemetzki H, Wigger-Alberti W
Future Microbiol. 2014;9(8 Suppl):S23-31.
Abstract

Digital Imaging for measuring of hair growth on the human scalp.
Hoffmann R, Lüdtke H, Hoffman-Wecker M, Hughes-Formella BJ
E. Berardesca et al. (eds); Non Invasive Diagnostic Techniques in Clinical Dermatology

Efficacy of a tyrothricin-containing wound gel in an abrasive wound model for superficial wounds.
Wigger-Alberti W, Stauss-Grabo M, Grigo K, Atiye S, Williams R, Korting HC
Skin Pharmacol Physiol. 2013;26(1):52-6.
Abstract

Efficacy and patient-reported outcomes of a new mometasone cream treating atopic eczema.
Ruzicka T, Willers C, Wigger-Alberti W
Skin Pharmacol Physiol. 2012;25(6):305-12.
Abstract

Tandem repeated irritation in aged skin induces distinct barrier perturbation and cytokine profile in vivo.
Angelova-Fischer I, Becker V, Fischer TW, Zillikens D, Wigger-Alberti W, Kezic S
Br J Dermatol. 2012 Oct;167(4):787-93.
Abstract

Bioavailability, antipsoriatic efficacy and tolerability of a new light cream with mometasone furoate 0.1%.
Korting HC, Schöllmann C, Willers C, Wigger-Alberti W
Skin Pharmacol Physiol. 2012;25(3):133-41.
Abstract

Comparison of the spread of three botulinum toxin type A preparations.
Kerscher M, Roll S, Becker A, Wigger-Alberti W
Arch Dermatol Res. 2012 Mar;304(2):155-61. Epub 2011 Oct 15.
Abstract

Interlaboratory studies with a proposed patch test design to evaluate the irritation potential of surfactants.
Mehling A, Chkarnat C, Degwert J, Ennen J, Fink E, Matthies W, Roethlisberger R, Rossow U, Schnitker J, Tronnier H, Wigger-Alberti W, Wilhelm KP
Contact Dermatitis. 2010 Mar;62(3):157-64.
Abstract

AN2728 demonstrates significant efficacy in three phase Ib psoriasis trials
Beutner K, Lathrop A, Marti D, Gassmueller J
JAAD, 2009;60:Supplement 1, 168

Validation of TrichoScan technology as a fully-automated tool for evaluation of hair growth parameters.
Gassmueller J, Rowold E, Frase T, Hughes-Formella B
Eur J Dermatol. 2009 May-Jun;19(3):224-31.
Abstract

Using a novel wound model to investigate the healing properties of products for superficial wounds.
Wigger-Alberti W, Kuhlmann M, Ekanayake S, Wilhelm D
J Wound Care. 2009 Mar;18(3):123-28, 131.
Abstract

Activity of different desoximetasone preparations compared to other topical corticosteroids in the vasoconstriction assay.
Borelli C, Gassmueller J, Fluhr JW, Nietsch KH, Schinzel S, Korting HC
Skin Pharmacol Physiol. 2008;21(3):181-7.
Abstract

Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
Gassmueller J, Hoffmann R, Webster A
Br J Dermatol. 2008 Jan;158(1):109-15.
Abstract

Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.
Görne RC, Greif C, Metzner U, Wigger-Alberti W, Elsner P
Skin Pharmacol Physiol. 2007;20(3):133-40.
Abstract

Anti-inflammatory and skin-hydrating properties of a dietary supplement and topical formulations containing oligomeric proanthocyanidins.
Hughes-Formella B, Wunderlich O, Williams R
Skin Pharmacol Physiol. 2007;20(1):43-9.
Abstract

Induction of a hardening phenomenon by repeated application of SLS: analysis of lipid changes in the stratum corneum.
Heinemann C, Paschold C, Fluhr J, Wigger-Alberti W, Schliemann-Willers S, Farwanah H, Raith K, Neubert R, Elsner P
Acta Derm Venereol. 2005;85(4):290-5.
Abstract

Transepidermal water loss dynamics of human vulvar and thigh skin.
Warren R, Bauer A, Greif C, Wigger-Alberti W, Jones MB, Roddy MT, Seymour JL, Hansmann MA, Elsner P
Skin Pharmacol Physiol. 2005 May-Jun;18(3):139-43.
Abstract

Percutaneous penetration of topically applied melatonin in a cream and an alcoholic solution.
Fischer TW, Greif C, Fluhr JW, Wigger-Alberti W, Elsner P
Skin Pharmacol Physiol. 2004 Jul-Aug;17(4):190-4.
Abstract

The atrophogenic potential and dermal tolerance of calcipotriol/betamethasone dipropionate ointment compared with betamethasone dipropionate ointment.
Traulsen J, Hughes-Formella BJ
Dermatology. 2003;207(2):166-72.
Abstract

The tandem repeated irritation test: a new method to assess prevention of irritant combination damage to the skin.
Wigger-Alberti W, Spoo J, Schliemann-Willers S, Klotz A, Elsner P
Acta Derm Venereol. 2002;82(2):94-7.
Abstract

The atopy patch test -- reproducibility and comparison of different evaluation methods.
Heinemann C, Schliemann-Willers S, Kelterer D, Metzner U, Kluge K, Wigger-Alberti W, Elsner P
Allergy. 2002 Jul;57(7):641-5.
Abstract

Different skin thinning potential of equipotent medium-strength glucocorticoids.
Korting HC, Unholzer A, Schäfer-Korting M, Tausch I, Gassmueller J, Nietsch KH
Skin Pharmacol Appl Skin Physiol. 2002 Mar-Apr;15(2):85-91.
Abstract

Anti-inflammatory efficacy of topical preparations with 10% hamamelis distillate in a UV erythema test.
Hughes-Formella BJ, Filbry A, Gassmueller J, Rippke F
Skin Pharmacol Appl Skin Physiol. 2002 Mar-Apr;15(2):125-32.
Abstract

Tandem application of sodium lauryl sulfate and n-propanol does not lead to enhancement of cumulative skin irritation.
Kappes UP, Göritz N, Wigger-Alberti W, Heinemann C, Elsner P
Acta Derm Venereol. 2001 Nov-Dec;81(6):403-5.
Abstract

Treating hypertrophic scars for 12 or 24 hours with a self-adhesive hydroactive polyurethane dressing.
Schmidt A, Gassmueller J, Hughes-Formella B, Bielfeldt S
J Wound Care. 2001 May;10(5):149-53.
Abstract

Experimental irritant contact dermatitis due to cumulative epicutaneous exposure to sodium lauryl sulphate and toluene: single and concurrent application.
Wigger-Alberti W, Krebs A, Elsner P
Br J Dermatol. 2000 Sep;143(3):551-6.
Abstract

Effects of various grit-containing cleansers on skin barrier function.
Wigger-Alberti W, Fischer T, Greif C, Maddern P, Elsner P
Contact Dermatitis. 1999 Sep;41(3):136-40.
Abstract

Experimentally induced chronic irritant contact dermatitis to evaluate the efficacy of protective creams in vivo.
Wigger-Alberti W, Caduff L, Burg G, Elsner P
J Am Acad Dermatol. 1999 Apr;40(4):590-6.
Abstract

Efficacy of protective creams in a modified repeated irritation test. Methodological aspects.
Wigger-Alberti W, Rougier A, Richard A, Elsner P
Acta Derm Venereol. 1998 Jul;78(4):270-3.
Abstract

Anti-inflammatory effect of hamamelis lotion in a UVB erythema test.
Hughes-Formella BJ, Bohnsack K, Rippke F, Benner G, Rudolph M, Tausch I, Gassmueller J
Dermatology. 1998;196(3):316-22.
Abstract

Self-application of a protective cream. Pitfalls of occupational skin protection.
Wigger-Alberti W, Maraffio B, Wernli M, Elsner P
Arch Dermatol. 1997 Jul;133(7):861-4.
Abstract

Validation of an in vivo wound healing model for the quantification of pharmacological effects on epidermal regeneration.
Lévy JJ, von Rosen J, Gassmüller J, Kleine Kuhlmann R, Lange L
Dermatology. 1995;190(2):136-41.
Abstract

Comparison of the effects of calcipotriol, prednicarbate and clobetasol 17-propionate on normal skin assessed by ultrasound measurement of skin thickness.
Lévy J, Gassmüller J, Schröder G, Audring H, Sönnichsen N
Skin Pharmacol. 1994;7(4):231-6.
Abstract

[Imaging subcutaneous atrophy in circumscribed scleroderma with 20 MHz B-scan ultrasound].
Lévy JJ, Gassmüller J, Audring H, Brenke A, Albrecht-Nebe H
Hautarzt. 1993 Jul;44(7):446-51.
Abstract